JD Health InternationalFRA:8ZN -2.94%90 Net Margin % is 7.28% as of Dec. 2025, which is 177% above its 10-year median of 2.63. GuruFocus rates FRA:8ZN with a GF Score™ of 90/100 and a GF Value™ of €6.33 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, JD Health International ranks better than 69.91% on this metric.
The historical rank and industry rank for JD Health International's Net Margin % or its related term are showing as below:
FRA:8ZN'
s Net Margin % Range Over the Past 10 Years
Min: -88.92 Med: 2.63 Max: 7.32
Current: 7.32
FRA:8ZN's Net Margin % is ranked better than 69.91% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs FRA:8ZN: 7.32
JD Health International (FRA:8ZN) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
JD Health International Net Margin % Related Terms
JD Health International Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Net Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Net Margin % distribution charts can be found below:
* The bar in red indicates where JD Health International's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (FRA:8ZN) has a Net Margin % of 7.28% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on JD Health International and its competitors. This is 177% above median its historical median of 2.63. According to the industry distribution chart, JD Health International ranks #201 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 30.1%.
Is JD Health International's Net Margin % too high?
JD Health International's current Net Margin % of 7.28% is 177% above median its 10-year median of 2.63. The Healthcare Providers & Services industry median Net Margin % is 2.89. JD Health International's value of 7.28% is 152.3% above this industry median. Based on the distribution chart, JD Health International ranks #201 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #201 out of 668 companies for Net Margin %. This puts JD Health International in the upper half of its industry. The industry median Net Margin % is 2.89. JD Health International's value of 7.28% is 152.3% above this benchmark. While the company's 10-year median is 2.63 vs. the industry median of 2.89, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current Net Margin % of 7.28% is 152.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Net Margin % is 7.28%, which is 177% above median its own 10-year median of 2.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
Based on GuruFocus' analysis, JD Health International (FRA:8ZN) is currently considered Significantly Undervalued. The stock's GF Value™ is €6.33, compared to a current price of €3.55 — trading 43.9% below its estimated fair value. The current Net Margin % is 7.28%, which is 177% above median its 10-year median of 2.63 and 152.3% above the Healthcare Providers & Services industry median of 2.89. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For JD Health International (FRA:8ZN), the current Net Margin % is 7.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (FRA:8ZN) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of €3.55 is trading 43.9% below its estimated GF Value™ of €6.33.
GuruFocus considers JD Health International to be Significantly Undervalued.
Key valuation signals for FRA:8ZN:
Net Margin %: 7.28% (177% above median its 10-year median of 2.63)
GF Value™: €6.33 vs. price of €3.55 (43.9% below fair value)
Industry Position: 152.3% above the Healthcare Providers & Services median (#201 of 668)
No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for FRA:8ZN
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8ZN has been successfully added to your 
